BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 3870548)

  • 21. Bacterial and clinical sequelae of the Twin bag system in continuous ambulatory peritoneal dialysis. A single centre study.
    Nubé MJ; de Vet JA; van Geelen JA
    Neth J Med; 1994 Jun; 44(6):191-7. PubMed ID: 8052341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved training techniques and UltraBag system resulted in lowered peritonitis rate in an inner-city population.
    Rubin JE; Marquardt E; Pierre M; Maxey RW
    Adv Perit Dial; 1995; 11():208-9. PubMed ID: 8534707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Testing the safety of non-disconnect disposable Y sets for peritoneal dialysis.
    Montenegro J; Echevarria J; Gonzalez R; Martinez I; Saracho R; Cruz C
    Adv Perit Dial; 1991; 7():183-5. PubMed ID: 1680421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peritonitis, pancreatitis, and infected pseudocyst in a continuous ambulatory peritoneal dialysis patient.
    Singh S; Wadhwa N
    Am J Kidney Dis; 1987 Jan; 9(1):84-6. PubMed ID: 3812483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of peritonitis with disconnect systems in CAPD: a randomized controlled trial. The Mexican Nephrology Collaborative Study Group.
    Monteón F; Correa-Rotter R; Paniagua R; Amato D; Hurtado ME; Medina JL; Salcedo RM; García E; Matos M; Kaji J; Vázquez R; Ramos A; Schettino MA; Moran J
    Kidney Int; 1998 Dec; 54(6):2123-8. PubMed ID: 9853278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro study of the efficacy of a two-way connection with disinfectant in the prevention of peritonitis.
    Buoncristiani U; Bianchi P; Nasimi M; Parlani F; Covarelli C; Buoncristiani E; Bastianini L; Bistoni F
    Adv Perit Dial; 2000; 16():208-12. PubMed ID: 11045295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage kidney disease.
    Daly C; Cody JD; Khan I; Rabindranath KS; Vale L; Wallace SA
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD003078. PubMed ID: 25117423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of vaccination in the prevention of staphylococcal peritonitis in continuous ambulatory peritoneal dialysis.
    Poole-Warren LA; Farrell PC
    Perit Dial Int; 1993; 13(3):176-7. PubMed ID: 8369344
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacokinetics of vancomycin in chronic renal failure patients in continuous ambulatory peritoneal dialysis (CAPD) after intra-abdominal administration].
    Mounier M; Benevent D; Denis F
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):542-4. PubMed ID: 3911152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CAPD disconnect systems.
    Junor BJ
    Blood Purif; 1989; 7(2-3):156-66. PubMed ID: 2663035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prevention of infection with Staphylococcus aureus in continuous ambulatory peritoneal dialysis.
    Ludlam H; McCann M
    J Hosp Infect; 1991 Apr; 17(4):324-6. PubMed ID: 1677667
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical experiences with a single use Y bagless CAPD system applying a quick disconnect clamp for external occlusion.
    Adcock A; Fox K; Jones D; Kenny R; Harbison J; Taber T; Bloomfield R
    Adv Perit Dial; 1991; 7():190-2. PubMed ID: 1680423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can we obtain a further reduction of peritonitis episodes in CAPD patients already using a Y-set with disinfectant?
    Viglino G; Gandolfo C; Cottino R; Mariano F; Goia F; Servetti L; Rivetti M; Cavalli PL
    Adv Perit Dial; 1990; 6():144-7. PubMed ID: 1982795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Our protocol in the treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis].
    Kostić S; Ljuvenović S; Velicković R; Stefanović V; Raicević R; Cukuranović R; Veljković S; Djordjević V; Malobabić Z
    Srp Arh Celok Lek; 1996; 124 Suppl 1():149-51. PubMed ID: 9102884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peritoneal drainage: an important element in host defence against staphylococcal peritonitis in patients on CAPD.
    Glancey GR; Cameron JS; Ogg CS
    Nephrol Dial Transplant; 1992; 7(7):627-31. PubMed ID: 1323074
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Transperitoneal resorption of cefotiam in CAPD patients with and without peritonitis].
    Thomae U; Koblinger S
    Med Klin (Munich); 1994 Sep; 89(9):464-8. PubMed ID: 7968880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generalized lymphadenopathy in continuous ambulatory peritoneal dialysis patients associated with Staphylococcus epidermidis infection.
    Pollock CA; Ibels LS
    Nephron; 1989; 52(1):81-2. PubMed ID: 2710271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does the response to hepatitis B vaccination predict CAPD-associated infections?
    Holley JL
    Adv Perit Dial; 1996; 12():218-20. PubMed ID: 8865907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can the risk of peritonitis be predicted for new continuous ambulatory peritoneal dialysis (CAPD) patients?
    Coles GA; Minors SJ; Horton JK; Fifield R; Davies M
    Perit Dial Int; 1989; 9(1):69-72. PubMed ID: 2488186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.